These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7755721)

  • 1. Screening for secondary causes of hyperlipidaemia in general practice. History should be considered before screening.
    Schwandt P; Richter WO
    BMJ; 1994 Nov; 309(6965):1374; author reply 1374-5. PubMed ID: 7755721
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for secondary causes of hyperlipidaemia in general practice. Correct diagnosis needs to be established.
    Reynolds TM; Wierzbicki AS; Feher MD
    BMJ; 1994 Nov; 309(6965):1373-4; author reply 1374-5. PubMed ID: 7866105
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for secondary causes of hyperlipidaemia in general practice. Misdiagnosis may result in litigation.
    Siriwardena AN
    BMJ; 1994 Nov; 309(6965):1374; author reply 1374-5. PubMed ID: 7866106
    [No Abstract]   [Full Text] [Related]  

  • 4. Screening for secondary causes of hyperlipidaemia in general practice. Assess against well recognised criteria.
    Thomson R
    BMJ; 1994 Nov; 309(6965):1374-5. PubMed ID: 7866107
    [No Abstract]   [Full Text] [Related]  

  • 5. Value of screening for secondary causes of hyperlipidaemia in general practice.
    Evans P; Gray DP
    BMJ; 1994 Aug 20-27; 309(6953):509-10. PubMed ID: 7755687
    [No Abstract]   [Full Text] [Related]  

  • 6. Health promotion: the ethical dimension.
    McCormick J
    Lancet; 1994 Aug; 344(8919):390-1. PubMed ID: 7914313
    [No Abstract]   [Full Text] [Related]  

  • 7. General practice fundholding. Non-fundholding groups better for everyone.
    Black DG; Trimble IM; Birchall AD; Fradd SO
    BMJ; 1994 Feb; 308(6926):476-7. PubMed ID: 8124201
    [No Abstract]   [Full Text] [Related]  

  • 8. Yield and costs of direct and stepped screening for depressive symptoms in subjects aged 75 years and over in general practice.
    van der Weele GM; de Waal MW; van den Hout WB; van der Mast RC; de Craen AJ; Assendelft WJ; Gussekloo J
    Int J Geriatr Psychiatry; 2011 Mar; 26(3):229-38. PubMed ID: 20665554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The primary prevention of atherosclerosis in general practice.
    Campbell IK
    J R Coll Gen Pract; 1978 Jul; 28(192):407-13. PubMed ID: 702455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up of screening for hyperlipidaemia.
    Mann J
    Nurs Times; 1991 Feb 6-12; 87(6):52. PubMed ID: 1996248
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for hyperlipidaemia: general practitioners' views.
    Whitehead S; Conridge P; Fender H
    BMJ; 1989 Aug; 299(6698):569. PubMed ID: 2507081
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for colorectal cancer: a general-practice-based study.
    Marjoram J; Strachan R; Allan A; Allan E
    Br J Gen Pract; 1996 May; 46(406):283-86. PubMed ID: 8762743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hyperlipidaemia in general practice.
    Qidwai W
    J Pak Med Assoc; 1998 Sep; 48(9):285-7. PubMed ID: 10028801
    [No Abstract]   [Full Text] [Related]  

  • 14. Costs of prevention. Prevention encompasses more than screening.
    Khaw KT
    BMJ; 1996 Mar; 312(7032):708. PubMed ID: 8597763
    [No Abstract]   [Full Text] [Related]  

  • 15. Preventive health screenings and health consultations in primary care increase life expectancy without increasing costs.
    Rasmussen SR; Thomsen JL; Kilsmark J; Hvenegaard A; Engberg M; Lauritzen T; Søgaard J
    Scand J Public Health; 2007; 35(4):365-72. PubMed ID: 17786799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counting the cost of social disadvantage in primary care. Authors excluded people who should have been included.
    West CA
    BMJ; 1997 Apr; 314(7089):1276. PubMed ID: 9154038
    [No Abstract]   [Full Text] [Related]  

  • 17. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
    Mason JM; Moayyedi P; Young PJ; Duffett S; Crocombe W; Drummond MF; Axon AT
    Int J Technol Assess Health Care; 1999; 15(4):649-60. PubMed ID: 10645106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NHS funds for fundholders and non-fundholders. Cost calculations are incorrect.
    Spenceley C; Craig N; Denham K; van Zwanenberg T
    BMJ; 1994 Oct; 309(6959):956; author reply 956-7. PubMed ID: 7950683
    [No Abstract]   [Full Text] [Related]  

  • 19. Educational outreach in diabetes to encourage practice nurses to use primary care hypertension and hyperlipidaemia guidelines (EDEN): a randomized controlled trial.
    New JP; Mason JM; Freemantle N; Teasdale S; Wong L; Bruce NJ; Burns JA; Gibson JM
    Diabet Med; 2004 Jun; 21(6):599-603. PubMed ID: 15154946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs of screening are important.
    Edgell C
    BMJ; 1993 Mar; 306(6880):797. PubMed ID: 8490365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.